Applied Clinical Trials Digital Edition - June/July 2014

Article

Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-06-01-2014
Volume 23
Issue 6

CRO/Sponsor: High Performing Study Startups Sites: RBM Challenges, Opportunities Trial Design: Three-pronged Monitoring Approach Study Recruitment: Enhancing Trial Enrollment Also in this issue: New EU Drug Legislation The Patient Experience Rebranding RBM

External Link - 2014-06ACT.pdf

Download Issue PDF
Articles in this issue
i4-845239-1408522739497.gif
Three-Pronged Approach to Optimizing Trial Monitoring
Half of All Drugs Today are Developed Through Collaborations
Half of All Drugs Today are Developed Through Collaborations
Event Examines Key Clinical Trial Adaptation Trends
Policymakers Seek New Ways to Streamline R&D and Approval
i1-845235-1408522751414.jpg
Rebranding 'Risk-Based Monitoring'
i1-845240-1408522736951.jpg
Engaging Tomorrow's Volunteers Through Museum Learning
i1-845231-1408522759873.jpg
Questions and Hopes on New EU Drug Legislation
i1-845236-1408522749559.jpg
ACT cover
i4-845234-1408522753042.gif
The Metrics Behind High Performing Study Startups
pr-845237-1408522747376.jpg
Enhancing Trial Enrollment Through 'Goal Programming'
i4-845238-1408522744066.gif
Shifting Monitoring Paradigms: Challenges and Opportunities
Applied Clinical Trials Digital Edition - June/July 2014
Recent Videos
Related Content
© FlowStudio - © FlowStudio - stock.adobe.com.

Using Data Patterns to Proactively Improve Study Quality

Sylviane de Viron;Steve Young
December 20th 2024
Article

Recent analysis showed 81% of clinical trial sites using RBQM statistical data monitoring experienced an improvement in quality.

Driving Diversity with the Integrated Research Model

Driving Diversity with the Integrated Research Model

Andy Studna, Editor
October 16th 2024
Podcast

Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.

© Minerva Studio - © Minerva Studio - stock.adobe.com

Palatin Announces Positive Results From Phase IIb BREAKOUT Study

Andy Studna, Editor
December 19th 2024
Article

In patients with type 2 diabetic nephropathy, bremelanotide demonstrated efficacy in reducing urine protein to creatinine ratio and improving or stabilizing estimated glomerular filtration rate.

AI in Clinical Trials: A Long, But Promising Road Ahead

AI in Clinical Trials: A Long, But Promising Road Ahead

Miranda Schmalfuhs
May 29th 2024
Podcast

Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.

© Sebastian Kaulitzki - © Sebastian Kaulitzki - stock.adobe.com..

Teva and Sanofi Share Positive Results from Phase II Study in Ulcerative Colitis and Crohn’s Disease

Andy Studna, Editor
December 18th 2024
Article

Duvakitug, a monoclonal antibody, demonstrated clinical remission and endoscopic response in the study, meeting its primary endpoints.

Credit: Mopic | stock.adobe.com

Imlunestrant Both as Monotherapy and in Combination Shows Promising Survival Benefits for ER-Positive, HER2-Negative Advanced Breast Cancer

Davy James
December 18th 2024
Article

Results from the EMBER-3 trial show imlunestrant, both as monotherapy and in combination with Verzenio (abemaciclib), significantly improved progression-free survival in ESR1-mutated ER-positive, HER2-negative advanced breast cancer.

© 2024 MJH Life Sciences

All rights reserved.